日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SARS-CoV-2 variants: biology, pathogenicity, immunity and control

SARS-CoV-2 变异株:生物学、致病性、免疫和控制

Uraki, Ryuta; Korber, Bette; Diamond, Michael S; Kawaoka, Yoshihiro

Efficacy of baloxavir marboxil against bovine H5N1 virus in mice

巴洛沙韦酯对小鼠牛H5N1病毒的疗效

Kiso, Maki; Uraki, Ryuta; Yamayoshi, Seiya; Kawaoka, Yoshihiro

Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures

SARS-CoV-2 病毒 NSP6 和 NSP13 中的氨基酸替换导致病毒在低温下生长能力增强。

Furusawa, Yuri; Kiso, Maki; Uraki, Ryuta; Sakai-Tagawa, Yuko; Nagai, Hiroyuki; Koga, Michiko; Kashima, Yukie; Hojo, Masayuki; Iwamoto, Noriko; Iwatsuki-Horimoto, Kiyoko; Ohmagari, Norio; Suzuki, Yutaka; Yotsuyanagi, Hiroshi; Halfmann, Peter J; Kamitani, Wataru; Yamayoshi, Seiya; Kawaoka, Yoshihiro

Transmission of bovine H5N1 virus in a hamster model

牛H5N1病毒在仓鼠模型中的传播

Iwatsuki-Horimoto, Kiyoko; Uraki, Ryuta; Ito, Mutsumi; Wang, Tong; Guan, Lizheng; Halfmann, Peter; Eisfeld, Amie; Neumann, Gabriele; Yamayoshi, Seiya; Kawaoka, Yoshihiro

An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strains in hamsters.

基于 XBB.1.5 的灭活 SARS-CoV-2 疫苗可对仓鼠中的 XBB.1.5 和 JN.1 毒株提供部分保护

Uraki Ryuta, Ito Mutsumi, Kiso Maki, Iwatsuki-Horimoto Kiyoko, Endo Masafumi, Yamayoshi Seiya, Kawaoka Yoshihiro

A human isolate of bovine H5N1 is transmissible and lethal in animal models.

从人体内分离出的牛源H5N1病毒具有传染性,并且在动物模型中具有致死性。

Gu Chunyang, Maemura Tadashi, Guan Lizheng, Eisfeld Amie J, Biswas Asim, Kiso Maki, Uraki Ryuta, Ito Mutsumi, Trifkovic Sanja, Wang Tong, Babujee Lavanya, Presler Robert Jr, Dahn Randall, Suzuki Yasuo, Halfmann Peter J, Yamayoshi Seiya, Neumann Gabriele, Kawaoka Yoshihiro

Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case.

在 Delta 突破性感染病例中诱导产生对 SARS-CoV-2(包括 Omicron 亚型)具有广泛中和活性的 IGHV3-53 公共抗体

Kuwata Takeo, Kaku Yu, Biswas Shashwata, Matsumoto Kaho, Shimizu Mikiko, Kawanami Yoko, Uraki Ryuta, Okazaki Kyo, Minami Rumi, Nagasaki Yoji, Nagashima Mami, Yoshida Isao, Sadamasu Kenji, Yoshimura Kazuhisa, Ito Mutsumi, Kiso Maki, Yamayoshi Seiya, Imai Masaki, Ikeda Terumasa, Sato Kei, Toyoda Mako, Ueno Takamasa, Inoue Takako, Tanaka Yasuhito, Kimura Kanako Tarakado, Hashiguchi Takao, Sugita Yukihiko, Noda Takeshi, Morioka Hiroshi, Kawaoka Yoshihiro, Matsushita Shuzo

An mRNA vaccine candidate encoding H5HA clade 2.3.4.4b protects mice from clade 2.3.2.1a virus infection

编码H5HA 2.3.4.4b分支的mRNA候选疫苗可保护小鼠免受2.3.2.1a分支病毒感染。

Chiba, Shiho; Kiso, Maki; Yamada, Shinya; Someya, Kazuhiko; Onodera, Yoshikuni; Yamaguchi, Aya; Matsunaga, Satoko; Uraki, Ryuta; Iwatsuki-Horimoto, Kiyoko; Yamayoshi, Seiya; Takeshita, Fumihiko; Kawaoka, Yoshihiro

Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters

仓鼠体内 Omicron BA.4.6、XBB 和 BQ.1.1 亚变体的特征分析

Halfmann, Peter J; Iwatsuki-Horimoto, Kiyoko; Kuroda, Makoto; Hirata, Yuichiro; Yamayoshi, Seiya; Iida, Shun; Uraki, Ryuta; Ito, Mutsumi; Ueki, Hiroshi; Furusawa, Yuri; Sakai-Tagawa, Yuko; Kiso, Maki; Armbrust, Tammy; Spyra, Sam; Maeda, Ken; Wang, Zhongde; Imai, Masaki; Suzuki, Tadaki; Kawaoka, Yoshihiro

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB

抗病毒药物对 Omicron 亚型 BQ.1.1 和 XBB 的疗效

Imai, Masaki; Ito, Mutsumi; Kiso, Maki; Yamayoshi, Seiya; Uraki, Ryuta; Fukushi, Shuetsu; Watanabe, Shinji; Suzuki, Tadaki; Maeda, Ken; Sakai-Tagawa, Yuko; Iwatsuki-Horimoto, Kiyoko; Halfmann, Peter J; Kawaoka, Yoshihiro